18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Prostate Cancer
Interventions
DRUG

Fluorocholine (18F-FCH) Injection

Before the PET-CT scan, the tracer (fluorocholine/FCH) will be injected into a vein in your arm just before the scan. This is the agent we are investigating in this study (not part of the standard procedure)

RADIATION

PET scan

A whole body PET scan will be performed, integrated with either whole body low dose CT or whole body MRI

RADIATION

Whole body MRI

A whole body MRI scan will be performed. This may be integrated with PET scan or performed separately.

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, University Health Network, 610 University Ave., Toronto

All Listed Sponsors
collaborator

Prostate Cancer Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT01993160 - 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer | Biotech Hunter | Biotech Hunter